News and Events

Paris, France et Camberley, Royaume-Uni – 26 mai 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce avoir été informé, le 25 mai 2020, d’achats d’actions ordinaires de 1/15 € chacune de la Société (les « Actions Ordinaires ») par l’Administrateur suivant : http://novacyt.com/wp-content/uploads/2020/05/Novacyt-Directors-Dealings-FRENCH-26.05.2020.pdf

Paris, France and Camberley, UK – 26 May 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 25 May 2020, the following Director purchased ordinary shares of €1/15 each in the Company (the “Ordinary Shares”): http://novacyt.com/wp-content/uploads/2020/05/Novacyt-Directors-Dealings-ENGLISH-26.05.2020.pdf

http://novacyt.com/wp-content/uploads/2020/12/27.-Novacyt-Directors-Dealings-RNS-ENGLISH-18.05.2020-GDM-and-JW.pdf